Result of AGM

Dechra Pharmaceuticals PLC
17 October 2007




Issued by Citigate Dewe Rogerson Limited, Birmingham
Date: 17 October 2007



                         Dechra(R) Pharmaceuticals PLC
                         (the 'Company' or the 'Group')
                   Results of Annual General Meeting ('AGM')


Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM
held today were duly passed by shareholders in attendance on a show of hands.

Copies of the following:

  • Ordinary resolution relating to the renewal of the authority for the
    directors to allot new shares;

  • Special resolution relating to the renewal of the authority for the
    directors to disapply pre-emption rights; and

  • Special resolution relating to the renewal of the authority for the
    Company to purchase its own shares;

being resolutions (other than resolutions concerning ordinary business) passed
by the Company at its AGM on 17 October 2007, have been submitted to the UK
Listing Authority and will shortly be available for publication at the UK
Listing Authority's Document Viewing Facility which is situated at :

    Financial Services Authority
    25 The North Colonnade
    Canary Wharf
    London E14 5HS

    Tel : [phone]


Details of the proxy voting instructions lodged prior to the AGM are set out
below:

Resolution                                                 For           Against     Discretionary   Abstained
(No. as noted on proxy form)


Resolution 1:                                              31,421,248    0           21,039          0
To receive and consider report and accounts

Resolution 2:                                              30,173,053    8,966       21,039          1,239,229
To receive and approve the Directors Remuneration Report

Resolution 3:                                              31,421,248    0           21,039          0
To declare a final dividend
(to be paid on 23 November 2007 to all members on the
register at close of business on 26 October 2007)

Resolution 4:                                              27,560,643    1,926,966   22,824          1,931,854
To re-elect Michael Redmond

Resolution 5:                                              31,417,355    1,500       22,824          608
To re-elect Edwin Torr

Resolution 6:                                              31,277,168    134,580     23,039          7,500
To re-appoint KPMG Audit plc as Auditors and to authorise
the directors to fix their remuneration

Resolution 7:                                              31,410,587    3,318       23,039          5,343
To grant authority to allot equity securities

Resolution 8:                                              31,406,407    3,110       29,307          3,463
To renew authority for pre-emptive allotment of equity
securities

Resolution 9:                                              31,402,753    5,081       27,162          7,291
To grant authority to the Company to purchase ordinary
shares




Enquiries:
Zoe Bamford, Company Secretary
Dechra Pharmaceuticals PLC
Tel: [phone]





Trade Marks appear throughout this release in italics.  Dechra and the Dechra 
'D' logo are registered Trade Marks of Dechra Pharmaceuticals PLC.


                      This information is provided by RNS
            The company news service from the London Stock Exchange